JPY6,634.00
0.59% today
Tokyo, May 21, 05:45 am CET
ISIN
JP3188220002
Symbol
4578
Index
Sector
Industry

Otsuka Stock price

JPY6,595.00
-15.00 0.23% 1M
-2,405.00 26.72% 6M
-2,005.00 23.31% YTD
+90.00 1.38% 1Y
+2,154.00 48.50% 3Y
+2,242.00 51.50% 5Y
+2,689.50 68.86% 10Y
Tokyo, Closing price Tue, May 20 2025
-45.00 0.68%
ISIN
JP3188220002
Symbol
4578
Index
Sector
Industry

Key metrics

Market capitalization JPY3.49t
Enterprise Value JPY3.38t
P/E (TTM) P/E ratio 10.13
EV/FCF (TTM) EV/FCF 10.12
EV/Sales (TTM) EV/Sales 1.41
P/S ratio (TTM) P/S ratio 1.46
P/B ratio (TTM) P/B ratio 1.32
Dividend yield 1.82%
Last dividend (FY25) JPY120.00
Revenue growth (TTM) Revenue growth 14.52%
Revenue (TTM) Revenue JPY2.39t
EBIT (operating result TTM) EBIT JPY430.59b
Free Cash Flow (TTM) Free Cash Flow JPY333.99b
Cash position JPY407.50b
EPS (TTM) EPS JPY650.72
P/E forward 11.74
P/S forward 1.44
EV/Sales forward 1.40
Show more

Is Otsuka a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Otsuka Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Otsuka forecast:

7x Buy
64%
4x Hold
36%

Analyst Opinions

11 Analysts have issued a Otsuka forecast:

Buy
64%
Hold
36%

Financial data from Otsuka

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,393,183 2,393,183
15% 15%
100%
- Direct Costs 665,277 665,277
6% 6%
28%
1,727,906 1,727,906
18% 18%
72%
- Selling and Administrative Expenses 868,038 868,038
17% 17%
36%
- Research and Development Expense 320,227 320,227
3% 3%
13%
539,641 539,641
33% 33%
23%
- Depreciation and Amortization 109,051 109,051
8% 8%
5%
EBIT (Operating Income) EBIT 430,590 430,590
41% 41%
18%
Net Profit 350,740 350,740
155% 155%
15%

In millions JPY.

Don't miss a Thing! We will send you all news about Otsuka directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following business segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. Its products include Bon Curry, Mannan Hikari, and ReSOLA. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded in1950 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Makoto Inoue
Employees 35,338
Founded 1921
Website www.otsuka.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today